Machine learning algorithms can accurately predict the gait speed of older patients with cancer, based on their response to questions addressing other aspects of functional status.

In order to meet the health needs of the coming "age wave", technology needs to be designed that supports remote health monitoring and assessment. In this study we design CIL, a clinician-in-the-loop visual interface, that provides clinicians with patient behavior patterns, derived from smart home data. A total of 60 experienced nurses participated in an iterative design of an interactive graphical interface for remote behavior monitoring. Results of the study indicate that usability of the system improves over multiple iterations of participatory design. In addition, the resulting interface is useful for identifying behavior patterns that are indicative of chronic health conditions and unexpected health events. This technology offers the potential to support self-management and chronic conditions, even for individuals living in remote locations.

Recognizing activities of daily living (ADLs) plays an essential role in analyzing human health and behavior. The widespread availability of sensors implanted in homes, smartphones, and smart watches have engendered collection of big datasets that reflect human behavior. To obtain a machine learning model based on these data,researchers have developed multiple feature extraction methods. In this study, we investigate a method for automatically extracting universal and meaningful features that are applicable across similar time series-based learning tasks such as activity recognition and fall detection. We propose creating a sequence-tosequence (seq2seq) model to perform this feature learning. Beside avoiding feature engineering, the meaningful features learned by the seq2seq model can also be utilized for semi-supervised learning. We evaluate both of these benefits on datasets collected from wearable and ambient sensors. CCS CONCEPTS• Theory of computation → Machine learning theory; Models of learning; Unsupervised learning and clustering; • Computing methodologies → Neural networks.

Deep neural networks (DNNs) have introduced novel and useful tools to the machine learning community. Other types of classifiers can potentially make use of these tools as well to improve their performance and generality. This paper reviews the current state of the art for deep learning classifier technologies that are being used outside of deep neural networks. Non-neural network classifiers can employ many components found in DNN architectures. In this paper, we review the feature learning, optimization, and regularization methods that form a core of deep network technologies. We then survey non-neural network learning algorithms that make innovative use of these methods to improve classification performance. Because many opportunities and challenges still exist, we discuss directions that can be pursued to expand the area of deep learning for a variety of classification algorithms.

Background The number of older patients with gastrointestinal cancer is increasing due to an aging global population. Minimizing reliance on an in-clinic patient performance status test to determine a patient’s prognosis and course of treatment can improve resource utilization. Further, current performance status measurements cannot capture patients' constant changes. These measurements also rely on self-reports, which are subjective and subject to bias. Real-time monitoring of patients' activities may allow for a more accurate assessment of patients’ performance status while minimizing resource utilization. Objective This study investigates the validity of consumer-based activity trackers for monitoring the performance status of patients with gastrointestinal cancer. Methods A total of 27 consenting patients (63% male, median age 58 years) wore a consumer-based activity tracker 7 days before chemotherapy and 14 days after receiving their first treatment. The provider assessed patients using the Eastern Cooperative Oncology Group Performance Status (ECOG-PS) scale and Memorial Symptom Assessment Scale-Short Form (MSAS-SF) before and after chemotherapy visits. The statistical correlations between ECOG-PS and MSAS-SF scores and patients’ daily step counts were assessed. Results The daily step counts yielded the highest correlation with the patients' ECOG-PS scores after chemotherapy (P<.001). The patients with higher ECOG-PS scores experienced a higher fluctuation in their step counts. The patients who walked more prechemotherapy (mean 6071 steps per day) and postchemotherapy (mean 5930 steps per day) had a lower MSAS-SF score (lower burden of symptoms) compared to patients who walked less prechemotherapy (mean 5205 steps per day) and postchemotherapy (mean 4437 steps per day). Conclusions This study demonstrates the feasibility of using inexpensive, consumer-based activity trackers for the remote monitoring of performance status in the gastrointestinal cancer population. The findings need to be validated in a larger population for generalizability.